Takeaway
Lower serum interleukin-33 (IL-33) levels were associated with worse prognosis and recurrence of acute ischemic stroke (AIS).
Why this matters
There is currently no biomarker that aids clinicians in evaluating and predicting outcomes associated with ischemic stroke.